Navigation Links
Sangamo BioSciences Announces Presentation of Top-Line Statistically Significant Phase 2 Data in Diabetic Neuropathy at Society for Neuroscience Meeting
Date:10/20/2009

RICHMOND, Calif., Oct. 20 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today the presentation of top-line, statistically significant Phase 2 clinical data from its ZFP Therapeutic(TM) program to develop SB-509 as a treatment for diabetic neuropathy (DN) at the Society for Neuroscience Annual Meeting held in Chicago.

Top-line data from Sangamo's SB-509-601 Phase 2 clinical trial demonstrated a direct neuroregenerative effect of SB-509 treatment that resulted in a statistically significant (p value=0.02) increase in small unmyelinated nerve fibers in the skin, or intraepidermal nerve fiber density (IENFD), in subjects with DN.

Data were also presented that provided additional evidence of the positive effect of SB-509 on large fiber sensory nerve health as measured by improvements in nerve conduction velocity (NCV), in subjects with elevated markers of vascular damage (ICAM-1), and improvements in the muscle components of the neurologic exam (NIS-LL) 30-days after each of the three administrations of SB-509. Together these data confirm the neuroregenerative activity of SB-509 in patients with DN and define a drug-responsive population for future trials.

"The IENFD data presented today provide direct histologic evidence of nerve regrowth with SB-509 treatment and a mechanistic proof of concept for the neuroregenerative effects of this ZFP Therapeutic," stated Dale Ando, M.D., Sangamo's Vice President of Therapeutic Development and Chief Medical Officer. "The relationship between reduced IENFD and severity of DN has been well established and correlates with decreased levels of VEGF-A and an increase in inflammatory growth factors such as ICAM-1, a marker of vascular disease. In addition, in subjects with more severe DN, with elevated levels of ICAM-1 in their blood, there is
'/>"/>

SOURCE Sangamo BioSciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. Sangamo BioSciences Presents Positive Phase 2 ZFP Therapeutic Data at ADA 2009
2. Sangamo BioSciences Announces Presentation at the JMP Securities Research Conference
3. Sangamo BioSciences Reports First Quarter 2009 Financial Results
4. Sangamo BioSciences Provides Update on Companys Accomplishments in 2007 and 2008 Objectives
5. Sangamo BioSciences to Present at the ThinkEquity Partners Growth Conference
6. Magellan Biosciences Sells its Life Sciences Tools Business to Dionex
7. Regado Biosciences Announces First Patient Enrolled in RADAR (Phase 2b) Study of REG1 Anticoagulation System
8. Neurocrine Biosciences to Present at the Thomas Weisel Partners Healthcare Conference
9. Cell Biosciences Launches Unique Protein Phosphorylation Assay Service
10. Sartorius Stedim Biotech Partners With Cell Culture Media Specialist SAFC Biosciences(R) to Provide World-Class Fluid Management and Liquid/Powder System Solutions
11. Catalyst Biosciences Announces Agreement With MedImmune to Discover and Develop Engineered Protease Therapeutics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... (PRWEB) March 04, 2015 As payers ... value-based payment contracts within the next few years, they ... the significant chunk of health care spending they control ... Inc.’s ACO Business News (ABN) tracks some of ... of a commercial accountable care organization (ACO)-type model. , ...
(Date:3/3/2015)... Anik Singal's Profit Academy - a ... has become the talk of the town throughout ... the course's general release has garnered the attention ... to review the program's content and publish an ... keys to success with Internet marketing is having ...
(Date:3/3/2015)... On February 24, 2015, a Toledo, ... States District Court for the Northern District of Ohio ... as insurance companies Balboa, QBE, and Newport Management. (See ... 3:14-cv-152.) , The Plaintiff, a Ms. Dolores Gorsuch, says ... her to buy too much insurance at rates that ...
(Date:3/3/2015)... March 03, 2015 NOVAtime Technology, ... enterprise Time and Attendance / Workforce Management solutions, ... NOVAtime SaaS Workforce Management / Time and ... attendance processes. , Since 2004, Innovative Services’ ... disabilities with the best quality of life. The ...
(Date:3/3/2015)... (PRWEB) March 03, 2015 Risperdal ... to market the atypical antipsychotic medication continue to ... to court documents, the South Carolina Supreme Court ... Johnson & Johnson’s Janssen Pharmaceuticals unit had deceptively ... However, while the Court’s February 25th decision characterized ...
Breaking Medicine News(10 mins):Health News:AIS Newsletter Examines Ways to Engage Specialists in Value-Based Payment Contracts 2Health News:AIS Newsletter Examines Ways to Engage Specialists in Value-Based Payment Contracts 3Health News:Anik Singal's Profit Academy - Review Of New IM Training Program Released 2Health News:Borrower Accuses Mortgage Lenders of Racketeering in Forcing Insurance on Homeowners 2Health News:Innovative Services, Inc. Successfully Migrates to Cloud-Based NOVAtime Workforce Management Solution to Support Growth and Improve Payroll Processing Time 2Health News:Innovative Services, Inc. Successfully Migrates to Cloud-Based NOVAtime Workforce Management Solution to Support Growth and Improve Payroll Processing Time 3Health News:Risperdal Lawsuit News: Bernstein Liebhard LLP Comments on Ruling Upholding South Carolina Jury Decision in Risperdal Marketing Case 2Health News:Risperdal Lawsuit News: Bernstein Liebhard LLP Comments on Ruling Upholding South Carolina Jury Decision in Risperdal Marketing Case 3
... New research shows bone marrow stem cells may help ... reporting at the American Heart //Association’s Scientific Sessions 2003 ... breakthrough trial that took place in 2001. Results from ... made from his own bone marrow had improved heart ...
... predict a person's risk of developing heart disease in ... finds childhood levels of low-density lipoprotein, or LDL, and ... wall thickness in young adults. The carotid artery is ... transports blood from the heart to the brain. Thickening ...
... are obese are more likely to have behavior problems ... University of Michigan studied more than 750 children between ... took part in the National Longitudinal Survey //of Youth ... health, education, demographic, and socioeconomic status. Children were classified ...
... in nearly half of the cases, Some pre-term births are ... //bleeding or stretching of the uterus. But in the rest, ... explain part of the problem. ,Premature birth -- when ... is a major public health concern because underdeveloped babies are ...
... the virus that killed 774 people remains unknown. Scientists believe people ... another source.// ,"You might want to quarantine the pets ... on emerging diseases at the University of Texas Medical Branch in ... cat to cat, it doesn't take much of a leap of ...
... creating a whole new experience for patients in dentist ... more smiles on their patients' faces.// ,Laser procedures ... removal, less bleeding and less discomfort for patients. There ... diagnose cavities, while others remove gum and tooth structure ...
Cached Medicine News:Health News:Elevated LDL levels in Childhood could be Predictors of Heart Disease 2Health News:Women who conceive after a year have a higher chance of giving birth prematurely 2Health News:Some pets found to be SARS carriers 2
(Date:3/3/2015)... 3, 2015  BioPharmX Corporation (OTCQB: BPMX), a specialty ... delivery products to address unmet needs in large, well-defined ... , chief executive officer and co-founder of BioPharmX, will ... Partners Conference on Wednesday, March 11 at 9:00 a.m. ... in Dana Point , California.   ...
(Date:3/3/2015)... DUBLIN , Mar. 03, 2015 Research and ... addition of the "Global POC Diagnostics Market 2015-2019" ... The analysts forecast the Global POC Diagnostics market to ... period 2014-2019. POC diagnostics are IVD ... outside a clinical laboratory setting. The use of these ...
(Date:3/3/2015)... 2015  Michigan brothers Dominique Larkin , 23, and ... ventricular dysplasia, or ARVD, a disease that causes irregular heart ... young athletes. In 2007, doctors discovered the condition ... later tested Dominique and found his "condition was just as ... story in The Ann Arbor News , part of ...
Breaking Medicine Technology:BioPharmX Corporation To Present At 27th Annual Roth Capital Partners Conference On March 11, 2015 2BioPharmX Corporation To Present At 27th Annual Roth Capital Partners Conference On March 11, 2015 3Global POC Diagnostics Market 2015-2019 with Abbott Labs, Alere, Bayer Healthcare, Danaher, F. Hoffmann-La Roche & Johnson & Johnson Dominating 2Younger of 2 Brothers on the SynCardia Total Artificial Heart Gets a Donor Heart Transplant 2Younger of 2 Brothers on the SynCardia Total Artificial Heart Gets a Donor Heart Transplant 3
... 2012 Nautilus Neurosciences, Inc., a neurology-focused specialty ... today that United States Patent and Trademark Office ... and methods of use." This patent relates to ... are also provided for treating symptoms that often ...
...  The national growth rate for psychiatric medication spending has ... researchers from Thomson Reuters (Healthcare) and the Substance Abuse ... http://photos.prnewswire.com/prnh/20090507/NY12658LOGO ) The paper, which ... Psychiatric Services , underlines falling prices of psychiatric ...
Cached Medicine Technology:Nautilus Neurosciences Announces New Patent Issued 2Psychiatric Medication Spending Growth Slows, According to New Thomson Reuters Research 2Psychiatric Medication Spending Growth Slows, According to New Thomson Reuters Research 3
Scoville-Greenwood bayonet forceps...
Angled 60 degree blades 5.5 mm....
... Accurately tests for Nystagmus when ... 10" high by 8" diameter. Light ... ball bearings for effortless spin mechanism. ... from patient. Includes both Adult and ...
Eschenbach's new 2636 series of stand magnifiers delivers the benefits of high power and a large fields of view. Using a unique doublet lens design, the 2636 offers the highest power recatngular lens...
Medicine Products: